EUCTR2021-006398-41-Outside-EU/EEA进行中（未招募）1 期
A Post-marketing Observational Study of Tazemetostat on Safety in Patients With Relapsed or Refractory Follicular Lymphoma With EZH2 Gene Mutation in Japan
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Subjects with with relapsed or refractory follicular lymphoma with EZH2 gene mutation.
- •2. Subjects treated with tazemetostat.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 1
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 44
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 100
排除标准
- •1. Subjects with a history of hypersensitivity to any ingredient of Tazverik.
研究者
相似试验
进行中（未招募）
不适用
A Study of Tazemetostat on Safety in Participants With Relapsed or Refractory Follicular Lymphoma With Enhancer of Zeste Homolog 2 (EZH2) Gene Mutation in JapanLymphoma, FollicularNCT05228158Eisai Co., Ltd.145
进行中（未招募）
1 期
/AInflamatory Bowel Disease (IBD)MedDRA version: 20.1 Level: LLT Classification code 10021973 Term: Inflammatory bowel disease NOS System Organ Class: 100000004856EUCTR2014-005192-89-FIHospira UK Ltd.2,500
已完成
不适用
Post-market clinical follow-up investigation of the marketed Extended Range of Vision IOL (Intraocular lens)h25H26Senile cataractOther cataractDRKS00005742Abbott Medical Optics Inc.147
进行中（未招募）
1 期
A Phase 1b/2 open-label study to test if Tazemetostat together with Enzalutamide or with Abiraterone/prednisone is effective in subjects with castration resistant prostate cancer that has spread and who have not yet received chemotherapy.EUCTR2019-003649-14-BEEpizyme, Inc.80
进行中（未招募）
不适用
A study to evaluate the effect of orlistat + resveratrol combination on weight managementObesity and overweightNutritional, Metabolic, EndocrineISRCTN10642495Zydus Lifesciences Ltd264